Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
W.R. Berkley
WRB
$27.1B
| $135M | 0.02% |
1,917,449
+16,144
| +0.8% | +$1.08M |
2013 Q2
52 quarters
|
|
627
Affirm
AFRM
$26.6B
| $135M | 0.02% |
1,656,971
+188,378
| +13% | +$12.3M |
2021 Q1
21 quarters
|
|
628
Roblox
RBLX
$35.5B
| $135M | 0.02% |
2,474,342
+81,017
| +3% | +$4.03M |
2021 Q3
19 quarters
|
|
629
Vornado Realty Trust
VNO
$6.32B
| $134M | 0.02% |
3,416,436
+205,989
| +6% | +$6.66M |
2013 Q2
52 quarters
|
|
630
Cytokinetics
CYTK
$8.72B
| $133M | 0.02% |
1,565,781
+168,736
| +12% | +$12.1M |
2013 Q3
51 quarters
|
|
631
BWX Technologies
BWXT
$12.9B
| $133M | 0.02% |
682,918
-6,449
| -0.9% | -$1.34M |
2013 Q2
52 quarters
|
|
632
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.24B
| $133M | 0.02% |
+1,236,240
| New | +$129M |
2026 Q2
0 quarters
|
|
633
Roku
ROKU
$22.7B
| $133M | 0.02% |
959,426
+3,501
| +0.4% | +$427K |
2017 Q4
34 quarters
|
|
634
Cooper Companies
COO
$10.6B
| $132M | 0.02% |
1,843,969
+38,303
| +2% | +$2.5M |
2013 Q2
52 quarters
|
|
635
Fabrinet
FN
$16.2B
| $132M | 0.02% |
234,878
-67,902
| -22% | -$43.8M |
2013 Q2
52 quarters
|
|
636
BrightSpring Health Services
BTSG
$12.4B
| $132M | 0.02% |
1,889,829
+302,233
| +19% | +$16.8M |
2024 Q1
9 quarters
|
|
637
Molina Healthcare
MOH
$10.7B
| $132M | 0.02% |
575,045
+35,733
| +7% | +$6.48M |
2013 Q2
52 quarters
|
|
638
Roivant Sciences
ROIV
$25B
| $131M | 0.02% |
3,715,594
+258,146
| +7% | +$7.63M |
2021 Q4
18 quarters
|
|
639
Globe Life
GL
$12.8B
| $131M | 0.02% |
734,319
-11,298
| -2% | -$1.77M |
2013 Q2
52 quarters
|
|
640
SoFi Technologies
SOFI
$19.8B
| $131M | 0.02% |
7,280,268
+809,882
| +13% | +$13.7M |
2021 Q3
19 quarters
|
|
641
CDW
CDW
$17.9B
| $130M | 0.02% |
921,916
+31,546
| +4% | +$3.96M |
2013 Q3
51 quarters
|
|
642
Insmed
INSM
$21.5B
| $129M | 0.02% |
1,213,963
+144,573
| +14% | +$17.5M |
2013 Q2
52 quarters
|
|
643
SPX Corp
SPXC
$8.45B
| $129M | 0.02% |
527,457
-106,721
| -17% | -$23.3M |
2013 Q2
52 quarters
|
|
644
Wintrust Financial
WTFC
$9.77B
| $129M | 0.02% |
801,412
-6,135
| -0.8% | -$923K |
2013 Q2
52 quarters
|
|
645
New York Times
NYT
$10.7B
| $129M | 0.02% |
1,836,277
-36,975
| -2% | -$2.85M |
2013 Q2
52 quarters
|
|
646
Everest Group
EG
$14.3B
| $128M | 0.02% |
359,268
+4,464
| +1% | +$1.53M |
2013 Q2
52 quarters
|
|
647
Baxter International
BAX
$12.8B
| $128M | 0.02% |
5,996,711
+407,157
| +7% | +$7.59M |
2013 Q2
52 quarters
|
|
648
BridgeBio Pharma
BBIO
$12.8B
| $127M | 0.02% |
1,709,417
-266,677
| -13% | -$18.7M |
2019 Q3
27 quarters
|
|
649
Ionis Pharmaceuticals
IONS
$7.28B
| $127M | 0.02% |
1,605,054
+21,788
| +1% | +$1.64M |
2013 Q2
52 quarters
|
|
650
Watts Water Technologies
WTS
$11.8B
| $127M | 0.02% |
325,015
-59,568
| -15% | -$18.6M |
2013 Q2
52 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.